This paper is in the following e-collection/theme issue:

mHealth for Rehabilitation (285) Pulmonology, COPD (155) mHealth for Symptom and Disease Monitoring, Chronic Disease Management (1503) mHealth in a Clinical Setting (653)

Published on in Vol 9, No 2 (2021): February

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/23548, first published .
WeChat as a Platform for Baduanjin Intervention in Patients With Stable Chronic Obstructive Pulmonary Disease in China: Retrospective Randomized Controlled Trial

WeChat as a Platform for Baduanjin Intervention in Patients With Stable Chronic Obstructive Pulmonary Disease in China: Retrospective Randomized Controlled Trial

WeChat as a Platform for Baduanjin Intervention in Patients With Stable Chronic Obstructive Pulmonary Disease in China: Retrospective Randomized Controlled Trial

Authors of this article:

Junjie Bi1 Author Orcid Image ;   Wei Yang1 Author Orcid Image ;   Ping Hao2 Author Orcid Image ;   Yongmei Zhao1 Author Orcid Image ;   Dan Wei1 Author Orcid Image ;   Yipeng Sun1 Author Orcid Image ;   Yuhua Lin1 Author Orcid Image ;   Meng Sun3 Author Orcid Image ;   Xuan Chen3 Author Orcid Image ;   Xuming Luo1 Author Orcid Image ;   Shanqun Li4 Author Orcid Image ;   Wei Zhang3 Author Orcid Image ;   Xiongbiao Wang1 Author Orcid Image
Article Authors Cited by (17) Tweetations (1) Metrics
All Time | Last Month | Last Six Months | Last Year
JMIR Publications JMIR Publications @jmirpub

New in JMIR mhealth: WeChat as a Platform for Baduanjin Intervention in Patients With Stable Chronic Obstructive Pu… https://t.co/3NA5AK2YTb

3:43 PM · Feb 02, 2021

0
0